On July 15th, the "2018 China Top 100 Pharmaceutical Industry Series List" selected by the Expert Committee of the Top 100 Chinese Pharmaceutical Industry was released, and Kangtai Biotech was shortlisted as the "Top 20 of China's Biomedical (including blood products, vaccines, insulin, etc.) 7th place in the leaderboard.

　　It is reported that the list is carried out by the expert committee, and at the same time, it relies on the three major terminals of the intranet to conduct quantitative analysis on the database of the six major market terminal patterns. Judgment.

　　In view of the fact that the core competitiveness factors of the major sub-sectors of the Chinese pharmaceutical industry are not the same, horizontal comparison cannot be forced. This list respects the opinions of experts and does not set up a general list, including "Top 100 Ranking of Chinese Chemical Pharmaceutical Enterprises", "Top 100 Ranking of Chinese Traditional Medicine Enterprises", "Top 20 Ranking of Chinese CRO (including CDMO) Enterprises", "Chinese Medical Devices (Including IVD) TOP20 list of enterprises "," Top 20 list of Chinese biomedicine (including blood products, vaccines, insulin, etc.) "list.